Literature DB >> 19838004

Ambulatory ECG-based T-wave alternans and heart rate turbulence predict high risk of arrhythmic events in patients with old myocardial infarction.

Shingo Maeda1, Mitsuhiro Nishizaki, Noriyoshi Yamawake, Takashi Ashikaga, Hiroshi Shimada, Mitsutoshi Asano, Kensuke Ihara, Tadashi Murai, Hidetoshi Suzuki, Hiroyuki Fujii, Harumizu Sakurada, Masayasu Hiraoka, Mitsuaki Isobe.   

Abstract

BACKGROUND: Few studies have explored risk stratification of arrhythmic events in patients with ischemic heart diseases according to T-wave alternans (TWA) using modified moving average (MMA) method and heart rate turbulence (HRT). METHODS AND
RESULTS: A retrospective analysis of 63 patients who underwent MMA-based TWA and HRT divided the patients into 3 groups: group-C of 21 controls, group-O of 21 patients with old myocardial infarction (OMI) showing no episodes of sustained ventricular tachyarrhythmia (SVT), and group-V of 21 OMI patients with episodes of SVT who received an implantable cardioverter-defibrillator. Among the 3 groups, positive TWA (>or=65 microV) and impaired HRT were observed most frequently in group-V (P<0.05). Using a logistic regression model, TWA yielded an odds ratio of 4.9 (95% confidence interval: 1.2-19.6, P<0.05), which was the only significant covariate for the incidence of life-threatening ventricular arrhythmias during a mean follow-up of 72 months.
CONCLUSIONS: Patients with OMI showing episodes of SVT have a high risk for cardiac death because of abnormal repolarization and autonomic regulation. The analysis of MMA-based TWA and HRT can be a useful tool for predicting OMI patients at high risk of arrhythmic events.

Entities:  

Mesh:

Year:  2009        PMID: 19838004     DOI: 10.1253/circj.cj-09-0420

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

1.  Comparison of standard versus orthogonal ECG leads for T-wave alternans identification.

Authors:  Laura Burattini; Sumche Man; Roberto Burattini; Cees A Swenne
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-04       Impact factor: 1.468

Review 2.  The year of 2009 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-10       Impact factor: 1.468

Review 3.  Usefulness of T-wave alternans in sudden death risk stratification and guiding medical therapy.

Authors:  Tuomo Nieminen; Richard L Verrier
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

4.  Intracoronary delivery of mesenchymal stem cells reduces proarrhythmogenic risks in swine with myocardial infarction.

Authors:  D Wang; Y Jin; C Ding; F Zhang; M Chen; B Yang; Q Shan; J Zou; K Cao
Journal:  Ir J Med Sci       Date:  2011-02-01       Impact factor: 1.568

5.  Dependency of exercise-induced T-wave alternans predictive power for the occurrence of ventricular arrhythmias from heart rate.

Authors:  Laura Burattini; Sumche Man; Sandro Fioretti; Francesco Di Nardo; Cees A Swenne
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

6.  T-wave alternans and heart rate variability: a comparison in patients with myocardial infarction with or without diabetes mellitus.

Authors:  LiNa Ren; XinHui Fang; Yongquan Wang; Guoxian Qi
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

Review 7.  Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology.

Authors:  Richard L Verrier; Thomas Klingenheben; Marek Malik; Nabil El-Sherif; Derek V Exner; Stefan H Hohnloser; Takanori Ikeda; Juan Pablo Martínez; Sanjiv M Narayan; Tuomo Nieminen; David S Rosenbaum
Journal:  J Am Coll Cardiol       Date:  2011-09-20       Impact factor: 24.094

8.  Effects of Trimetazidine on T Wave Alternans in Stable Coronary Artery Disease.

Authors:  Mehmet Yaman; Uğur Arslan; Hasan Ali Gümrükçüoğlu; Musa Şahin; Hakkı Şimşek; Serkan Akdağ
Journal:  Korean Circ J       Date:  2016-04-26       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.